The Journal of Organic Chemistry
Article
C32H28O2N2: C, 81.33; H, 5.97; N, 5.93. Found: C, 81.15; H, 5.99;
N, 6.02.
(1-benzyl-2-(4-(bis(2-(trityloxy)ethyl)amino)styryl)-6-methylpyridin-
4(1H)-ylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (JE-1Tr) as an
orange amorphous powder was obtained. IR (paraffin oil) υ, cm−1:
3425, 3386, 3168, 3083, 3058, 3025, 2966, 2925, 2877, 2813, 1706,
1657, 1614, 1588, 1526, 1464. 1H NMR (CDCl3, 300 MHz): δ 9.36 (s,
1H, major conformer), 9.36 (s, 1H, major conformer), 9.13 (s, 1H,
minor conformer), 9.06 (s, 1H, minor conformer), 8.95 (s, 1H, major
conformer), 7.69−7.03 (m, 44H), 6.86−6.77 (m, 2H, minor con-
former), 6.64 (d, 1H, J = 12.4 Hz, minor conformer), 6.57 (d, 1H, J =
15.6 Hz, major conformer), 6.44 (d, 2H, J = 8.7 Hz, major conformer),
6.37 (d, 2H, J = 8.9 Hz, minor conformer), 5.43 (s, 2H, major
conformer), 5.29 (s, 2H, minor conformer), 3.57 (s, 4H), 3.26 (s, 4H),
2.53 (s, 3H, major conformer), 2.40 (s, 3H, minor conformer). 13C{1H}
NMR (CDCl3, 300 MHz): δ 165.1, 143.9, 141.3, 129.8, 129.4, 128.6,
127.8, 127.0, 125.2, 122.6, 118.0, 116.9, 112.6, 111.6, 112.6, 111.6,
104.3, 87.1, 70.0, 61.0, 51.0, 21.1. Anal. Calcd for C67H58O5N4: C,
80.54; H, 5.85; N, 5.85. Found: C, 80.29; H, 5.94; N, 5.69.
5-(1-Benzyl-2-(4-(bis(2-(trityloxy)ethyl)amino)styryl)-6-methyl-
pyridin-4(1H)-ylidene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-tri-
one (ME-1Tr) was synthesized by the general method I from 5-(2-(4-
(bis(2-(trityloxy)ethyl)amino)styryl)-6-methyl-4H-pyran-4-ylidene)-
1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (MWK-1) (0.27 g,
0.27 mmol) and benzylamine (1.0 mL, 9.16 mmol). After the required
workup and additional purification by liquid column chromatography
(silica gel, V(triethylamine)/V(ethyl acetate)/V(dichloromethane) =
1:10:40 solvent system), 0.25 g (89%) of 5-(1-benzyl-2-(4-(bis(2-
(trityloxy)ethyl)amino)styryl)-6-methylpyridin-4(1H)-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (ME-1Tr) as a yellow
amorphous powder was obtained. IR (paraffin oil) υ, cm−1: 3079, 3059,
3027, 2964, 2924, 2882, 1696, 1688, 1623, 1601, 1589, 1520, 1479,
1462, 1406. 1H NMR (CDCl3, 300 MHz): δ 9.37 (s, 1H, major
conformer), 9.17 (s, 1H, minor conformer), 9.11 (s, 1H, minor
conformer), 9.00 (s, 1H, major conformer), 7.47−7.01 (m, 42H),
6.86−6.78 (m, 1H, mixture of conformers), 6.64−6.52 (m, 2H, mixture
of conformers), 6.43 (d, 2H, J = 8.5 Hz, major conformer), 6.35 (d, 2H,
J = 8.9 Hz, minor conformer), 6.05 (d, 1H, J = 12.7 Hz, minor
conformer), 5.42 (s, 2H, major conformer), 5.27 (s, 2H, minor
conformer), 3.56 (s, 4H), 3.41 (s, 6H, major conformer), 3.36 (s, 6H,
minor conformer), 3.26 (s, 4H), 2.51 (s, 3H, major conformer), 2.39 (s,
3H, minor conformer). 13C{1H} NMR (CDCl3, 300 MHz): δ 164.4,
155.4, 152.4, 150.4, 149.2, 147.6, 143.9, 140.8, 133.5, 129.7, 129.2,
128.6, 127.8, 127.0, 121.2, 118.4, 113.1, 111.5, 89.6, 87.1, 61.1, 53.2,
51.0, 27.9, 21.2. Anal. Calcd for C69H62O5N4: C, 80.68; H, 6.08; N,
5.45. Found: C, 80.44; H, 6.15; N, 5.52.
5-(1-Benzyl-2-(4-(bis(2-(trityloxy)ethyl)amino)styryl)-6-methyl-
pyridin-4(1H)-ylidene)-1,3-diethyl-2-thioxodihydropyrimidine-4,6-
(1H,5H)-dione (EE-1Tr) was synthesized by general method I from 5-
(2-(4-(bis(2-(trityloxy)ethyl)amino)styryl)-6-methyl-4H-pyran-4-yli-
dene)-1,3-diethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
(EWK-1) (0.17 g, 0.17 mmol) and benzylamine (1.0 mL, 9.16 mmol).
After the required workup and additional purification by liquid column
chromatography (silica gel, V(triethylamine)/V(ethyl acetate)/V-
(dichloromethane) = 1:10:40 solvent system), 0.09 g (85%) of 5-(1-
benzyl-2-(4-(bis(2-(trityloxy)ethyl)amino)styryl)-6-methylpyridin-
4(1H)-ylidene)-1,3-diethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-
dione (EE-1Tr) as an orange amorphous powder was obtained. IR
(paraffin oil) υ, cm−1: 3650, 3459, 3051, 3029, 3022, 2987, 2970, 2950,
2929, 2867, 1738, 1728, 1656, 1651, 1619, 1586, 1554, 1521, 1481,
1448, 1420. 1H NMR (CDCl3, 300 MHz): δ 9.31 (s, 1H, major
conformer), 9.17 (s, 1H, minor conformer), 9.11 (s, 1H, minor
conformer), 8.95 (s, 1H, major conformer), 7.47−7.01 (m, 41H),
6.85−6.76 (m, 2H, mixture of conformers), 6.64 (d, 1H, J = 12.4 Hz,
minor conformer), 6.57 (d, 1H, J = 15.7 Hz, major conformer), 6.45 (d,
2H, J = 8.8 Hz, major conformer), 6.36 (d, 2H, J = 9.0 Hz, minor
conformer), 6.06 (d, 1H, J = 12.0 Hz, minor conformer), 5.44 (s, 2H,
major conformer), 5.30 (s, 2H, minor conformer), 4.75−4.59 (m, 4H),
3.55 (m, 4H), 3.26 (m, 4H), 2.54 (s, 3H, major conformer), 2.42 (s, 3H,
minor conformer), 1.42−1.27 (m, 6H). 13C{1H} NMR (CDCl3, 300
MHz): δ 177.0, 162.1, 155.4, 150.8, 149.4, 147.9, 143.9, 141.3, 133.2,
129.8, 129.4, 128.6, 127.8, 127.0, 125.2, 119.6, 112.7, 111.6, 87.00, 61.1,
5-(1-Benzyl-2-(4-(dimethylamino)styryl)-6-methylpyridin-4(1H)-
ylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (JE-1) was synthesized by
general method I from 5-(2-(4-(dimethylamino)styryl)-6-methyl-4H-
pyran-4-ylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (3) (0.16 g,
0.438 mmol) and about 20 equiv of benzylamine (1.0 mL, 9.16
mmol). After the required workup, 0.16 g (80%) of 5-(1-benzyl-2-(4-
(dimethylamino)styryl)-6-methylpyridin-4(1H)-ylidene)pyrimidine-
2,4,6(1H,3H,5H)-trione (JE-1) as a dark-yellow powder with an mp >
300 °C (dec.) was obtained. IR (paraffin oil) υ, cm−1: 3136, 3083, 2956,
2921, 2851, 2804, 1715, 1687, 1663, 1587, 1532, 1463, 1414. 1H NMR
(CDCl3, 300 MHz): δ 9.37 (s, 1H, minor conformer), 9.11 (s, 1H,
major conformer), 9.05 (s, 1H, major conformer), 8.97 (s, 1H, minor
conformer), 7.45−7.34 (m, 5H), 7.08−7.04 (d, 2H, J = 8.0 Hz, minor
conformer), 7.01−6.90 (m, 4H, major conformer), 6.75−6.70 (d, 1H, J
= 12.4 Hz, major conformer), 6.11−6.05 (d, 1H, J = 12.1 Hz, major
conformer), 5.46 (s, 2H, minor conformer), 5.43 (s, 2H, major
conformer), 3.02 (s, 6H, minor conformer), 2.99 (s, 6H, major
conformer), 2.55 (s, 3H, minor conformer), 2.54 (s, 3H, major
conformer). 13C{1H} NMR (DMSO-d6, 300 MHz): δ 165.7, 165.6,
153.9, 151.7, 150.8, 150.7, 150.3, 149.4, 139.5, 137.0, 135.8, 135.2,
130.8, 129.6, 128.2, 126.1, 123.3, 122.1, 120.0, 119.5, 116.2, 115.1,
112.3, 112.1, 87.8, 52.7, 21.6. Anal. Calcd for C27H26O4N3: C, 71.35; H,
5.77; N, 12.33. Found: C, 71.35; H, 5.77; N, 12.33.
Attempted synthesis of 1-benzyl-2-(4-(dimethylamino)styryl)-6-
methylpyridin-4(1H)-ylidene-malononitrile (DE-1) was carried out
by general method I from 2-(4-(dimethylamino)styryl)-6-methyl-4H-
pyran-4-ylidene)malononitrile (1) (0.21 g, 0.693 mmol) and about 20
equiv of benzylamine (1.0 mL, 9.16 mmol). After the required workup,
0.13 g (38%) of N-benzyl-2-(1-benzyl-2-(4-(dimethylamino)styryl)-6-
methylpyridin-4(1H)-ylidene)-2-cyanoacetimidamide (DE-1*) as a
1
yellow amorphous powder with an mp of 209 °C was obtained. H
NMR (CDCl3, 300 MHz): δ 11.19 (s, 1H), 7.57 (d, 1H, J = 15.6 Hz),
7.40 (d, 4H, J = 7.8 Hz), 7.31−7.09 (m, 10H), 6.76 (d, 1H, J = 15.7 Hz),
6.65 (d, 2H, J = 8.5 Hz), 6.23 (s, 1H), 5.83 (s, 1H), 4.90 (s, 2H), 4.81 (s,
2H), 2.93 (s, 6H), 2.19 (s, 3H). 13C{1H} NMR (CDCl3, 300 MHz): δ
157.6, 157.0, 155.2, 150.4, 143.6, 135.1, 133.2, 129.3, 128.4, 128.3,
127.8, 127.7, 126.5, 125.4, 124.1, 112.4, 105.2, 104.1, 103.5, 48.3, 45.2,
40.4, 21.3. Anal. Calcd for C33H33N5: C, 79.33; H, 6.66; N, 14.02.
Found: C, 78.98; H, 6.62; N, 13.70.
2-(1-Benzyl-2-(4-(bis(2-(trityloxy)ethyl)amino)styryl)-6-methyl-
pyridin-4(1H)-ylidene)-1H-indene-1,3(2H)-dione (ZE-1Tr) was syn-
thesized by general method I from 2-(2-(4-(bis(2-(trityloxy)ethyl)-
amino)styryl)-6-methyl-4H-pyran-4-ylidene)-1H-indene-1,3(2H)-
dione (ZWK-1)24 (0.10 g, 0.11 mmol) and benzylamine (0.5 mL, 4.08
mmol). After the required workup, 0.10 g (86.4%) of 2-(1-benzyl-2-(4-
(bis(2-(trityloxy)ethyl)amino)styryl)-6-methylpyridin-4(1H)-yli-
dene)-1H-indene-1,3(2H)-dione (ZE-1Tr) as an orange amorphous
powder was obtained. IR (paraffin oil) υ, cm−1: 3088, 3060, 3024, 2921,
2851, 1673, 1661, 1629, 1592, 1580, 1532, 1521, 1504, 1463, 1456. 1H
NMR (CDCl3, 300 MHz): δ 9.09 (s, 1H, major conformer), 8.80 (s,
1H, minor conformer), 8.74 (s, 1H, minor conformer), 8.66 (s, 1H,
major conformer), 7.62−7.55 (m, 2H), 7.46−7.41 (m, 2H), 7.39−6.99
(m, 40H), 6.81 (d, 2H, J = 7.8 Hz, major conformer), 6.56 (s, 1H, J =
12.6 Hz, minor conformer), 6.49 (s, 1H, J = 15.6 Hz, major conformer),
6.37 (d, 2H, J = 8.6 Hz, major conformer), 6.29 (d, 2H, J = 8.5 Hz), 5.91
(d, 1H, J = 12.4 Hz, minor conformer), 5.31 (s, 2H, major conformer),
5.17 (s, 2H, minor conformer), 3.56−3,41 (m, 4H), 3.26−3.14 (m,
4H), 2.43 (s, 3H, major conformer), 2.30 (s, 3H, minor conformer).
13C{1H} NMR (CDCl3, 300 MHz): δ 186.1, 183.6, 143.9, 140.4, 128.6,
127.9, 127.8, 127.0, 110.6, 102.7, 66.6, 64.3, 61.0, 60.8, 21.0. Anal.
Calcd for C72H60O4N2: C, 85.01; H, 5.95; N, 2.75. Found: C, 84.75; H,
6.09; N, 3.06.
5-(1-Benzyl-2-(4-(bis(2-(trityloxy)ethyl)amino)styryl)-6-methyl-
pyridin-4(1H)-ylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (JE-1Tr)
was synthesized by general method I from 5-(2-(4-(bis(2-(trityloxy)-
ethyl)amino)styryl)-6-methyl-4H-pyran-4-ylidene)pyrimidine-2,4,6-
(1H,3H,5H)-trione (JWK-1)24 (0.16 g, 0.17 mmol) and benzylamine
(0.8 mL, 7.32 mmol). After the required workup, 0.17 g (96.8%) of 5-
3219
J. Org. Chem. 2021, 86, 3213−3222